 nimodipine (marketed by bayer as nimotop) is a dihydropyridine calcium channel blocker originally developed for the treatment of high blood pressure. it is not frequently used for this indication, but has shown good results in preventing a major complication of subarachnoid hemorrhage (a form of cerebral hemorrhage) termed vasospasm; this is now the main use of nimodipine. ==dosage== the regular dosage is 60&nbsp;mg tablets every four hours. if the patient is unable to take tablets orally, it was previously given via intravenous infusion at a rate of 1â2&nbsp;mg/hour (lower dosage if the body weight is <70&nbsp;kg or blood pressure is too low), but since the withdrawal of the iv preparation, administration by nasogastric tube is an alternative. ==usage== because it has some selectivity for cerebral vasculature, nimodipine's main use is in the prevention of cerebral vasospasm and resultant ischemia, a com
Calcium_channel_blockers Carboxylate_esters Dihydropyridines Ethers Nitrobenzenes